Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. demonstrates robust business quality, financial strength, and capital allocation, supported by consistent revenue and profit growth. While profitability metrics are healthy, the current valuation appears stretched relative to the calculated intrinsic value.
Business Performance (CAGR)
Valuation Snapshot
Financial Health
Profitability Metrics
Cash Flow Intelligence
Intrinsic Value
PremiumEstimated Intrinsic Value & DCF Fair Value are available with Premium plans.
AI Business Verdict
Dr. Lal Path Labs exhibits robust operational performance and exceptional financial health, underscored by consistent growth and strong profitability. However, its current market valuation appears to be at a significant premium to its calculated intrinsic value, suggesting limited margin of safety for new positions.
- Excellent financial health with low debt and high interest coverage.
- Robust profitability metrics, including strong ROE, ROCE, and operating margins.
- Consistent double-digit growth in revenue, PAT, and EPS.
- Strong free cash flow generation and efficient cash conversion cycle.
Balance Sheet
Dr. Lal Path Labs Ltd. maintains an exceptionally strong balance sheet with significant cash reserves, very low leverage, strong equity growth and financial flexibility.
Capacity to fund growth, withstand downturns and return capital.
- Dr.
- Lal Path Labs Ltd.
- maintains an exceptionally strong balance sheet with significant cash reserves, very low leverage, strong equity growth and financial flexibility.
- Net cash position — debt fully covered by cash & investments
- Large cash & investment reserves
- Very low leverage with net cash balance
- Strong shareholder equity growth
- High interest coverage
- Comfortable short-term liquidity cushion
- Large 'other assets' bucket — investigate composition